Multidrug resistance to HIV-1 protease inhibition requires cooperative coupling between distal mutations.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Biochemistry

• Publication date

  2003-11-25

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI0350405PMID 14622012
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW，Thompson RW，et al//Proc Natl Acad Sci U S A

  2005cited by this paper
• Designing drugs against heterogeneous targets

  2002cited by this paper
• A Potent Human Immunodeficiency Virus Type 1 Protease Inhibitor, UIC-94003 (TMC-126), and Selection of a Novel (A28S) Mutation in the Protease Active Site

  2002cited by this paper
• Overcoming drug resistance in HIV‐1 chemotherapy: The binding thermodynamics of Amprenavir and TMC‐126 to wild‐type and drug‐resistant mutants of the HIV‐1 protease

  2002cited by this paper
• Amplification of the effects of drug resistance mutations by background polymorphisms in HIV-1 protease from African subtypes.

  2002cited by this paper
• Anisotropic dynamics of the JE-2147-HIV protease complex: drug resistance and thermodynamic binding mode examined in a 1.09 A structure.

  2002cited by this paper
• The binding energetics of first- and second-generation HIV-1 protease inhibitors: implications for drug design.

  2001cited by this paper
• Structural and kinetic analysis of drug resistant mutants of HIV-1 protease.

  2000cited by this paper
• Thermodynamic basis of resistance to HIV-1 protease inhibition: calorimetric analysis of the V82F/I84V active site resistant mutant.

  2000cited by this paper
• Thermodynamic dissection of the binding energetics of KNI‐272, a potent HIV‐1 protease inhibitor

  2000cited by this paper
• Exact analysis of competition ligand binding by displacement isothermal titration calorimetry.

  2000cited by this paper
• The effect of inhibitor binding on the structural stability and cooperativity of the HIV‐1 protease

  1999cited by this paper
• JE-2147: a dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1.

  1999cited by this paper
• Domain flexibility in retroviral proteases: structural implications for drug resistant mutations.

  1998cited by this paper
• Thermodynamics and proton uptake for pepstatin binding to retroviral and eukaryotic aspartic proteases.

  1998cited by this paper
• The structural stability of the HIV-1 protease.

  1998cited by this paper
• Dissection of the pH dependence of inhibitor binding energetics for an aspartic protease: direct measurement of the protonation states of the catalytic aspartic acid residues.

  1997cited by this paper
• Molecular basis of HIV-1 protease drug resistance: structural analysis of mutant proteases complexed with cyclic urea inhibitors.

  1997cited by this paper
• Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV.

  1997cited by this paper
• Crystal structures of complexes of a peptidic inhibitor with wild-type and two mutant HIV-1 proteases.

  1996cited by this paper
• In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

  1995cited by this paper
• Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatine.

  1995cited by this paper
• Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure.

  1995cited by this paper
• Thermodynamic mapping of the inhibitor site of the aspartic protease endothiapepsin.

  1995cited by this paper
• Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease.

  1994cited by this paper
• Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor

  1994cited by this paper
• Vitamins and Hormones

  1946cited by this paper

• Identifiable factor analysis for mixed continuous and binary variables based on the Gaussian-Grassmann distribution

  2025cites this paper
• Identifiability and improper solutions in the probabilistic partial least squares regression with unique variance

  2025cites this paper
• Predicting binding strength and dissociation kinetics of HIV-1 protease inhibitors Ritonavir, XK-263, and AHA-001 by molecular simulations.

  2025cites this paper
• Factors Influencing the Binding of HIV‐1 Protease Inhibitors: Insights from Machine Learning Models

  2025cites this paper
• Dynamical responses predict a distal site that modulates activity in an antibiotic resistance enzyme

  2024cites this paper
• Binding kinetics of highly mutated HIV-1 subtype C protease inhibition by Lopinavir and Darunavir in the face of altered conformational dynamics.

  2024cites this paper
• Assessing the functional impact of protein binding site definition

  2023cites this paper
• Mechanism of a high free-energy transduction efficiency of Bacillus PS3 F1-ATPase from the perspective of solvent entropy

  2023cites this paper
• Mutation Effects on Structure and Dynamics: Adaptive Evolution of the SARS-CoV-2 Main Protease

  2023cites this paper
• Evolving Mutational Buildup in HIV-1 Protease Shifts Conformational Dynamics to Gain Drug Resistance

  2023cites this paper
• SARS-CoV-2 Main Protease Inhibitors Repurposed for HIV-1 Protease Binding

  2022cites this paper
• Crystallographic and enzyme kinetics studies of multidrug resistant HIV-1 protease mutants PR20 and PRS17

  2022cites this paper
• Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat

  2021cites this paper
• Revertant mutation V48G alters conformational dynamics of highly drug resistant HIV protease PRS17.

  2021cites this paper
• Investigating potency of TMC-126 against wild-type and mutant variants of HIV-1 protease: a molecular dynamics and free energy study

  2021cites this paper
• An Additive Graphical Model for Discrete Data

  2021cites this paper
• Acquired HIV-1 Protease Conformational Flexibility Associated with Lopinavir Failure May Shape the Outcome of Darunavir Therapy after Antiretroviral Therapy Switch

  2021cites this paper
• The hydrophobic effect: is water afraid, or just not that interested?

  2020cites this paper
• A synergy of activity, stability, and inhibitor‐interaction of HIV‐1 protease mutants evolved under drug‐pressure

  2020cites this paper
• Pharmacokinetic Parameters of HIV‐1 Protease Inhibitors

  2020cites this paper
• Highly drug-resistant HIV-1 protease reveals decreased intra-subunit interactions due to clusters of mutations.

  2020cites this paper
• pM to µM - Elucidating the Role of Distal Mutations in HIV-1 Protease in Conferring Drug Resistance.

  2019cites this paper
• Picomolar to Micromolar: Elucidating the Role of Distal Mutations in HIV ‑ 1 Protease in Conferring Drug Resistance

  2019cites this paper
• Characterizing early drug resistance-related events using geometric ensembles from HIV protease dynamics

  2018cites this paper
• Characterizing drug resistance using geometric ensembles from HIV protease dynamics

  2018cites this paper
• An inhibitor-interaction intermediate of HIV-1 protease, revealed by Isothermal Titration Calorimetry and NMR spectroscopy

  2018cites this paper
• How Mutations Can Resist Drug Binding yet Keep HIV-1 Protease Functional.

  2017cites this paper
• Drug Resistance to HIV-1 Protease Inhibitors: Molecular Mechanisms and Substrate Coevolution

  2017cites this paper
• Polymorphisms and Mutational Covariation Associated with Death in a Prospective Cohort of HIV/AIDS Patients Receiving Long-Term ART in China

  2017cites this paper
• Forbidden Coherence Transfer of 19F Nuclei to Quantitatively Measure the Dynamics of a CF3-Containing Ligand in Receptor-Bound States

  2017cites this paper
• Sequence, Structural Analysis and Metrics to Define the Unique Dynamic Features of the Flap Regions Among Aspartic Proteases

  2017cites this paper
• Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS.

  2016cites this paper
• Enthalpy screen of drug candidates.

  2016cites this paper
• Binding of clinical inhibitors to a model precursor of a rationally selected multidrug resistant HIV-1 protease is significantly weaker than to the released mature enzyme

  2016cites this paper
• Improvement of Ligand Affinity and Thermodynamic Properties by NMR-Based Evaluation of Local Dynamics and Surface Complementarity in the Receptor-Bound State.

  2016cites this paper
• Binding of Clinical Inhibitors to a Model Precursor of a Rationally Selected Multidrug Resistant HIV-1 Protease Is Significantly Weaker Than That to the Released Mature Enzyme.

  2016cites this paper
• Improving Viral Protease Inhibitors to Counter Drug Resistance.

  2016cites this paper
• Knowledge-based approaches for understanding structure-dynamics-function relationship in proteins

  2016cites this paper
• Concluding Remarks: Mechanism of Functional Expression Common in the Molecular Machines

  2016cites this paper
• New 1(2H)-phthalazinone derivatives as potent nonpeptidic HIV-1 protease inhibitors: molecular docking studies, molecular dynamics simulation, oral bioavailability and ADME prediction

  2016cites this paper
• A Functional Interplay between Human Immunodeficiency Virus Type 1 Protease Residues 77 and 93 Involved in Differential Regulation of Precursor Autoprocessing and Mature Protease Activity

  2015cites this paper
• Mutations Proximal to Sites of Autoproteolysis and the α-Helix That Co-evolve under Drug Pressure Modulate the Autoprocessing and Vitality of HIV-1 Protease.

  2015cites this paper
• Highly resistant HIV-1 proteases and strategies for their inhibition.

  2015cites this paper
• Identifying representative drug resistant mutants of HIV

  2015cites this paper
• Distributions of experimental protein structures on coarse-grained free energy landscapes.

  2015cites this paper
• HIV Drug Resistant Prediction and Featured Mutants Selection using Machine Learning Approaches

  2014cites this paper
• Defective Hydrophobic Sliding Mechanism and Active Site Expansion in HIV-1 Protease Drug Resistant Variant Gly48Thr/Leu89Met: Mechanisms for the Loss of Saquinavir Binding Potency

  2014cites this paper
• Natural polymorphisms and unusual mutations in HIV-1 protease with potential antiretroviral resistance: a bioinformatic analysis

  2014cites this paper
• Systematic molecular dynamics, MM-PBSA, and ab initio approaches to the saquinavir resistance mechanism in HIV-1 PR due to 11 double and multiple mutations.

  2014cites this paper
• Structure-based design of conformationally flexible reverse transcriptase inhibitors to combat resistant HIV.

  2014cites this paper
• Resistance mechanism of human immunodeficiency virus type-1 protease to inhibitors: A molecular dynamic approach

  2014cites this paper
• Computing Clinically Relevant Binding Free Energies of HIV-1 Protease Inhibitors

  2014cites this paper
• Why is Substrate Peptide Binding Unsusceptible to Multidrug-Resistant Mutations in HIV-1 Protease? A Structural and Energetic Analysis

  2014cites this paper
• Structure, Activity, and Inhibition of the Carboxyltransferase β-Subunit of Acetyl Coenzyme A Carboxylase (AccD6) from Mycobacterium tuberculosis

  2014cites this paper
• Cooperative effects of drug-resistance mutations in the flap region of HIV-1 protease.

  2013cites this paper
• MM/GBSA Binding Energy Prediction on the PDBbind Data Set: Successes, Failures, and Directions for Further Improvement

  2013cites this paper
• The Role of Second Generation Antiretroviral Drugs in HIV-1 Subtype B and non-B Variants Harboring Natural Polymorphisms and Drug Resistance Mutations.

  2013cites this paper
• Crystallographic Study of HIV Protease Drug Resistant Variants and Green Fluorescent Protein Based Calcium Sensor CatchER

  2013cites this paper
• Regulation of human and HIV-1 splice sites

  2013cites this paper
• Extreme entropy-enthalpy compensation in a drug-resistant variant of HIV-1 protease.

  2012cites this paper
• Carbonylhydrazide-based molecular tongs inhibit wild-type and mutated HIV-1 protease dimerization.

  2012cites this paper
• Alkyl hydroxybenzoic acid derivatives that inhibit HIV-1 protease dimerization.

  2012cites this paper
• Regularized Learning of High-dimensional Sparse Graphical Models

  2012cites this paper
• Quantized water access to the HIV-1 protease active site as a proposed mechanism for cooperative mutations in drug affinity.

  2012cites this paper
• 9.3 In Silico Coarse-Grained Approaches to Structural Dynamics and Function of Proteins and their Assemblies

  2012cites this paper
• Challenging Disciplinary Boundaries in the First Year: A New Introductory Integrated Science Course for STEM Majors

  2012cites this paper
• Towards Personalised Drug Ranking in Clinical Decision Support

  2012cites this paper
• Hydrophobic core flexibility modulates enzyme activity in HIV-1 protease.

  2012cites this paper
• Target-drug interactions: first principles and their application to drug discovery.

  2012cites this paper
• Structural, kinetic, and thermodynamic studies of specificity designed HIV‐1 protease

  2012cites this paper
• Nonconcave penalized composite conditional likelihood estimation of sparse Ising models

  2012cites this paper
• Towards high-throughput, high-performance computational estimation of binding affinities for patient specific HIV-1 protease sequences

  2011cites this paper
• Role of Protein Flexibility in Function, Resistance Pathways and Substrate Recognition Specific ity in HIV-1 Protease: A Dissertation

  2011cites this paper
• Catalytic contributions from remote regions of enzyme structure.

  2011cites this paper
• Elucidating the energetics of entropically driven protein-ligand association: calculations of absolute binding free energy and entropy.

  2011cites this paper
• Molecular dynamics simulation of drug resistance in HIV-1 protease and reverse transcriptase

  2011influential citation
• Rotation mechanism of F1-ATPase: crucial importance of the water entropy effect.

  2011cites this paper
• Looking at the proteases from a simple perspective

  2011cites this paper
• Reaction kinetics of catalyzed competitive heteropolymer cleavage.

  2011cites this paper
• Resolution of Discordant HIV-1 Protease Resistance Rankings Using Molecular Dynamics Simulations

  2011cites this paper
• Role of Protein Flexibility in Function, ResistancePathways and Substrate Recognition Specificity in HIV-1 Protease: A Dissertation

  2011cites this paper
• Combining sequence and structure information to model biological systems dynamics

  2011influential citation
• First‐Generation HIV‐1 Protease Inhibitors for the Treatment of HIV/AIDS

  2011cites this paper
• Adsorption of xenon on a protein arising from the translational motion of solvent molecules.

  2010cites this paper
• Accurate Ensemble Molecular Dynamics Binding Free Energy Ranking of Multidrug-Resistant HIV-1 Proteases

  2010cites this paper
• Explicit solvent dynamics and energetics of HIV‐1 protease flap opening and closing

  2010cites this paper
• General Framework of Pressure Effects on Structures Formed by Entropically Driven Self-Assembly

  2010cites this paper
• Exploring Molecular Mechanisms of Drug Resistance in HIV-1 Protease through Biochemical and Biophysical Studies: A Dissertation

  2010cites this paper
• Modeling Protein-Ligand Binding by Mining Minima.

  2010cites this paper
• Molecular Mechanics Studies of Enzyme Evolutionary Mechanisms

  2010cites this paper
• Molecular dynamics simulations of complex systems including HIV-1 protease

  2010cites this paper
• Computational mutation scanning and drug resistance mechanisms of HIV-1 protease inhibitors.

  2010cites this paper
• Mutation of Asn28 disrupts the dimerization and enzymatic activity of SARS 3CL(pro) .

  2010cites this paper
• Three-Dimensional Density Profiles of Small and Medium Spheres near a Pair of Large Spheres: Relevance to Entropic Interaction Induced between Large Spheres

  2009cites this paper
• Coarse-Grained Modeling of the HIV-1 Protease Binding Mechanisms: I. Targeting Structural Flexibility of the Protease Flaps and Implications for Drug Design

  2009cites this paper
• Pressure effects on structures formed by entropically driven self-assembly: illustration for denaturation of proteins.

  2009cites this paper
• Pairwise and higher-order correlations among drug-resistance mutations in HIV-1 subtype B protease

  2009cites this paper
• Solute effects on spin labels at an aqueous-exposed site in the flap region of HIV-1 protease.

  2009cites this paper
• Recent developments in isothermal titration calorimetry label free screening.

  2009cites this paper
• Dimer disruption and monomer sequestration by alkyl tripeptides are successful strategies for inhibiting wild-type and multidrug-resistant mutated HIV-1 proteases.

  2009cites this paper